http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31095629

Outgoing Links

Predicate Object
contentType Journal Article|Randomized Controlled Trial|Research Support, N.I.H., Extramural
endingPage 185.e2
issn 0022-3476
pageRange 177-185.e2
publicationName The Journal of Pediatrics
startingPage 177
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4f4f68130529edca593878ba30c2ef39
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cd56c8adab61729d0b2330596228ab6e
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1f3fa33da726b432943daf318ff706e3
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_959cbf6cd03a95923465e3db5bcfce87
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_71694f2dd88fbe11a989fc3c47cd45e5
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_959c721ca52e90d3815b0d0a0e0abe61
bibliographicCitation Smaldone A, Findley S, Manwani D, Jia H, Green NS. HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease. The Journal of Pediatrics. 2018 Jun;197():177–185.e2. doi: 10.1016/j.jpeds.2018.01.054.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5edebae49f956babbec823cdecebddf9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f0edc264c33c141be236f181f036b8d0
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8326-5036
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c71fe18cfe428806108d3d6a4ad33b1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-9877-1561
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c54fb6fd13a9e721f41b6ec475962c0
date 201806
identifier https://doi.org/10.1016/j.jpeds.2018.01.054
https://pubmed.ncbi.nlm.nih.gov/29571930
https://pubmed.ncbi.nlm.nih.gov/PMC5970970
isPartOf https://portal.issn.org/resource/ISSN/0022-3476
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5127
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title HABIT, a Randomized Feasibility Trial to Increase Hydroxyurea Adherence, Suggests Improved Health-Related Quality of Life in Youths with Sickle Cell Disease
discusses http://id.nlm.nih.gov/mesh/M0010790
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D055118Q000706
http://id.nlm.nih.gov/mesh/D000755Q000188
http://id.nlm.nih.gov/mesh/D006918Q000627
http://id.nlm.nih.gov/mesh/D003150Q000706
http://id.nlm.nih.gov/mesh/D001521Q000379
hasSubjectTerm http://id.nlm.nih.gov/mesh/D002648
http://id.nlm.nih.gov/mesh/D000293
http://id.nlm.nih.gov/mesh/D010290
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D005240
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D060145
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3657

Total number of triples: 47.